BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31781088)

  • 1. Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents' Perspective on Ataxia Telangiectasia.
    Blom M; Schoenaker MHD; Hulst M; de Vries MC; Weemaes CMR; Willemsen MAAP; Henneman L; van der Burg M
    Front Immunol; 2019; 10():2438. PubMed ID: 31781088
    [No Abstract]   [Full Text] [Related]  

  • 2. Early diagnosis of ataxia telangiectasia in the neonatal phase: a parents' perspective.
    Schoenaker MHD; Blom M; de Vries MC; Weemaes CMR; van der Burg M; Willemsen MAAP
    Eur J Pediatr; 2020 Feb; 179(2):251-256. PubMed ID: 31709473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands.
    Blom M; Bredius RGM; Jansen ME; Weijman G; Kemper EA; Vermont CL; Hollink IHIM; Dik WA; van Montfrans JM; van Gijn ME; Henriet SS; van Aerde KJ; Koole W; Lankester AC; Dekkers EHBM; Schielen PCJI; de Vries MC; Henneman L; van der Burg M;
    J Clin Immunol; 2021 Jan; 41(1):99-108. PubMed ID: 33070266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for SCID identifies patients with ataxia telangiectasia.
    Mallott J; Kwan A; Church J; Gonzalez-Espinosa D; Lorey F; Tang LF; Sunderam U; Rana S; Srinivasan R; Brenner SE; Puck J
    J Clin Immunol; 2013 Apr; 33(3):540-9. PubMed ID: 23264026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Confirmation of DNA Repair Defect in Ataxia Telangiectasia (AT) Infants Identified by Newborn Screening for Severe Combined Immunodeficiency (NBS SCID).
    Barmettler S; Coffey K; Smith MJ; Chong HJ; Pozos TC; Seroogy CM; Walter J; Abraham RS
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):723-732.e3. PubMed ID: 32818697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Diagnosis of Ataxia Telangiectasia Through Newborn Screening for SCID: a Case Report Highlighting the Dilemma of Pre-emptive HSCT.
    Weitering TJ; Willemsen MAAP; Taylor AMR; Weemaes CMR; van der Burg M; Berghuis D
    J Clin Immunol; 2023 Nov; 43(8):1770-1773. PubMed ID: 37624468
    [No Abstract]   [Full Text] [Related]  

  • 7. Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.
    Mandola AB; Reid B; Sirror R; Brager R; Dent P; Chakroborty P; Bulman DE; Roifman CM
    Front Immunol; 2019; 10():2940. PubMed ID: 31921190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.
    Boyarchuk O; Yarema N; Kravets V; Shulhai O; Shymanska I; Chornomydz I; Hariyan T; Volianska L; Kinash M; Makukh H
    Front Immunol; 2022; 13():999664. PubMed ID: 36189201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information and Emotional Support Needs of Families Whose Infant Was Diagnosed With SCID Through Newborn Screening.
    Raspa M; Lynch M; Squiers L; Gwaltney A; Porter K; Peay H; Huston A; Fitzek B; Boyle JG
    Front Immunol; 2020; 11():885. PubMed ID: 32435251
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
    de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
    Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
    Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M; Bartoshesky LE; Bonilla FA; Brokopp C; Brooks E; Caggana M; Celestin J; Church JA; Comeau AM; Connelly JA; Cowan MJ; Cunningham-Rundles C; Dasu T; Dave N; De La Morena MT; Duffner U; Fong CT; Forbes L; Freedenberg D; Gelfand EW; Hale JE; Hanson IC; Hay BN; Hu D; Infante A; Johnson D; Kapoor N; Kay DM; Kohn DB; Lee R; Lehman H; Lin Z; Lorey F; Abdel-Mageed A; Manning A; McGhee S; Moore TB; Naides SJ; Notarangelo LD; Orange JS; Pai SY; Porteus M; Rodriguez R; Romberg N; Routes J; Ruehle M; Rubenstein A; Saavedra-Matiz CA; Scott G; Scott PM; Secord E; Seroogy C; Shearer WT; Siegel S; Silvers SK; Stiehm ER; Sugerman RW; Sullivan JL; Tanksley S; Tierce ML; Verbsky J; Vogel B; Walker R; Walkovich K; Walter JE; Wasserman RL; Watson MS; Weinberg GA; Weiner LB; Wood H; Yates AB; Puck JM; Bonagura VR
    JAMA; 2014 Aug; 312(7):729-38. PubMed ID: 25138334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for treatable and untreatable disorders: prospective parents' opinions.
    Plass AM; van El CG; Pieters T; Cornel MC
    Pediatrics; 2010 Jan; 125(1):e99-106. PubMed ID: 20026497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for SCID: lessons learned.
    Buelow BJ; Verbsky JW; Routes JM
    Expert Rev Hematol; 2016 Jun; 9(6):579-84. PubMed ID: 27139719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time.
    Quinn J; Orange JS; Modell V; Modell F
    Immunol Res; 2020 Feb; 68(1):48-53. PubMed ID: 32128663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel.
    Lev A; Sharir I; Simon AJ; Levy S; Lee YN; Frizinsky S; Daas S; Saraf-Levy T; Broides A; Nahum A; Hanna S; Stepensky P; Toker O; Dalal I; Etzioni A; Stein J; Adam E; Hendel A; Marcus N; Almashanu S; Somech R
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2722-2731.e9. PubMed ID: 35487367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia Detected Through Combined T Cell Receptor Excision Circle and Next Generation Sequencing of Newborn Dried Blood Spots.
    Al-Mousa H; Al-Dakheel G; Jabr A; Elbadaoui F; Abouelhoda M; Baig M; Monies D; Meyer B; Hawwari A; Dasouki M
    Front Immunol; 2018; 9():782. PubMed ID: 29713328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Screening for Severe Combined Immunodeficiency: 10-Year Experience at a Single Referral Center (2009-2018).
    Thorsen J; Kolbert K; Joshi A; Baker M; Seroogy CM
    J Clin Immunol; 2021 Apr; 41(3):595-602. PubMed ID: 33409868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
    Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
    Front Immunol; 2020; 11():1948. PubMed ID: 33178177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of Universal Newborn Screening for Severe Combined Immunodeficiency in Singapore While Continuing Routine Bacille-Calmette-Guerin Vaccination Given at Birth.
    Chan SB; Zhong Y; Lim SCJ; Poh S; Teh KL; Soh JY; Chong CY; Thoon KC; Seng M; Tan ES; Arkachaisri T; Liew WK
    Front Immunol; 2021; 12():794221. PubMed ID: 35046952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parents' views on accepting, declining, and expanding newborn bloodspot screening.
    van der Pal SM; Wins S; Klapwijk JE; van Dijk T; Kater-Kuipers A; van der Ploeg CPB; Jans SMPJ; Kemp S; Verschoof-Puite RK; van den Bosch LJM; Henneman L
    PLoS One; 2022; 17(8):e0272585. PubMed ID: 35980961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.